These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23259573)

  • 1. HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma.
    Liang PI; Li WM; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Wei YC; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Lin CM; Li CF
    BMC Cancer; 2012 Dec; 12():611. PubMed ID: 23259573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expression.
    Sun DP; Lin CY; Tian YF; Chen LT; Lin LC; Lee SW; Hsing CH; Lee HH; Shiue YL; Huang HY; Li CF; Liang PI
    Tumour Biol; 2013 Oct; 34(5):3059-69. PubMed ID: 23722602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular localisation of anillin is associated with different survival outcomes in upper urinary tract urothelial carcinoma.
    Liang PI; Chen WT; Li CF; Li CC; Li WM; Huang CN; Yeh HC; Ke HL; Wu WJ; Chai CY
    J Clin Pathol; 2015 Dec; 68(12):1026-32. PubMed ID: 26135313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High cytoplasmic HuR expression is associated with advanced pT stage, high grade and increased microvessel density in urothelial bladder carcinoma.
    Fus ŁP; Pihowicz P; Koperski Ł; Marczewska JM; Górnicka B
    Ann Diagn Pathol; 2018 Apr; 33():40-44. PubMed ID: 29566946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HuR cytoplasmic expression is associated with increased cyclin A expression and inferior disease-free survival in patients with gastrointestinal stromal tumours (GISTs).
    Wei YC; Chou FF; Li CF; Li WM; Chen YY; Lan J; Li SH; Fang FM; Hu TH; Yu SC; Eng HL; Uen YH; Tian YF; Wang JC; Huang HY
    Histopathology; 2013 Oct; 63(4):445-54. PubMed ID: 23889148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
    Chang IW; Lin VC; Hung CH; Wang HP; Lin YY; Wu WJ; Huang CN; Li CC; Li WM; Wu JY; Li CF
    World J Urol; 2015 Nov; 33(11):1777-89. PubMed ID: 25813210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
    Li WM; Wei YC; Huang CN; Ke HL; Li CC; Yeh HC; Chang LL; Huang CH; Li CF; Wu WJ
    J Surg Oncol; 2016 May; 113(6):700-7. PubMed ID: 26861489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.
    Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ
    J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
    Li WM; Huang CN; Ke HL; Li CC; Wei YC; Yeh HC; Chang LL; Huang CH; Liang PI; Yeh BW; Chan TC; Li CF; Wu WJ
    Oncotarget; 2016 Nov; 7(47):77777-77792. PubMed ID: 27780919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
    Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
    J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
    Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
    Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
    Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
    Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma.
    Zhang C; Xue G; Bi J; Geng M; Chu H; Guan Y; Wang J; Wang B
    Tumour Biol; 2014 Jan; 35(1):73-80. PubMed ID: 23873103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive and prognostic significance of cytoplasmic expression of ELAV-like protein HuR in invasive breast cancer treated with neoadjuvant chemotherapy.
    Wang J; Li D; Wang B; Wu Y
    Breast Cancer Res Treat; 2013 Sep; 141(2):213-24. PubMed ID: 24036660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis.
    Bolenz C; Fernández MI; Trojan L; Hoffmann K; Herrmann E; Steidler A; Weiss C; Ströbel P; Alken P; Michel MS
    BJU Int; 2009 Apr; 103(8):1040-6. PubMed ID: 18990139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of HuR in cytoplasm, but not nuclei, is associated with malignant aggressiveness and prognosis in bladder cancer.
    Miyata Y; Watanabe S; Sagara Y; Mitsunari K; Matsuo T; Ohba K; Sakai H
    PLoS One; 2013; 8(3):e59095. PubMed ID: 23516604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
    D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
    Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non-Lymph Node Distant Metastasis.
    Sevillano E; Werner L; Bossé D; Lalani AA; Wankowicz SAM; de Velasco G; Farina M; Lundgren K; Choueiri TK; González Del Alba A; Bellmunt J
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1089-e1094. PubMed ID: 28864222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected High-Risk Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy for Adjuvant Chemotherapy: A Multi-Institutional Retrospective Study.
    Ikeda M; Matsumoto K; Hirayama T; Koguchi D; Murakami Y; Matsuda D; Okuno N; Utsunomiya T; Taoka Y; Irie A; Iwamura M
    Clin Genitourin Cancer; 2018 Jun; 16(3):e669-e675. PubMed ID: 29239844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.